Skip to main content
main-content

Melanoma

19-04-2017 | Melanoma | Highlight | Article

Editor's pick

Surgical resection still important in abdominal melanoma metastases

Patients who undergo surgical resection of abdominal visceral melanoma metastases have significantly better overall survival than those who do not, and the outcome is not greatly improved by modern systemic treatments, study findings indicate.

Source:

JAMA Surg 2017; Advance online publication

14-03-2017 | Melanoma | News | Article

Binimetinib extends NRAS-mutated metastatic melanoma PFS

Binimetinib could be incorporated into the treatment pathway of patients with advanced melanoma harboring NRAS mutations, say researchers who found a progression-free survival benefit with the MEK inhibitor over dacarbazine.

Source:

Lancet Oncol 2017; Advance online publication

01-03-2017 | Melanoma | News | Article

Large-scale melanoma screening ‘feasible’ in large healthcare systems

The rate of melanoma diagnoses can be doubled with routine screening by full-body skin examination and is feasible within a large healthcare system, US study data show.

Source:

JAMA Oncol 2017; Advance online publication

27-02-2017 | Melanoma | News | Article

Immunotherapy trial eligibility criteria exclude majority of metastatic melanoma patients

Over half of patients with metastatic melanoma do not meet eligibility criteria for participation in phase III clinical trials of immunotherapy agents, highlight study findings.

Source:

Eur J Cancer 2017; 74: 89–95

03-11-2016 | Melanoma | News | Article

Editor's pick

Melanoma survival extension with adjuvant ipilimumab comes at toxicity cost

Updated phase III trial results show that ipilimumab treatment improves overall survival and distant metastasis-free survival in stage III melanoma patients who have undergone complete resection, but with increased toxicity relative to placebo.

Source:

N Engl J Med 2016; Advance online publication; ESMO 2016; Copenhagen, Denmark

20-09-2016 | Melanoma | News | Article

News in brief

High factor sunscreen protects against melanoma

Using sunscreen with a sun protection factor of at least 15 may be key to reducing the risk of melanoma.

image credits